Owner Scorecard


← All companies ← LLYVK Manual LMB → ← LIVN Medical Devices & Equipment MASI →

LMAT, LeMaitre Vascular Inc.

We are a global provider of medical devices and human tissue cryopreservation services largely used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease.

We develop, manufacture, and market vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons.

Our diversified portfolio of devices consists of brand name products that are used in arteries and veins and are well known to vascular surgeons.

Latest annual: FY2025 10-K
LMAT · LeMaitre Vascular Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$250M
+13.5% YoY · 14% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $256M 5-yr avg $196M
Gross margin 72% 5-yr avg 67%
Operating margin 28.5% 5-yr avg 22.0%
ROIC 10% 5-yr avg 10%
Owner-earnings margin 31% 5-yr avg 19%
Free cash flow margin 31% 5-yr avg 19%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What moves the needle
Gross margin has run about 68% and operating margin about 21% through the cycle, a wide spread between price and the cost of what it sells — whether that advantage is durable pricing power or a margin that can erode is the question the record is for. Inventory runs near 22% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on customer concentration, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has sat near the cost of capital (median 12%). By owner earnings: roughly 16% of revenue reaches owners as cash, consistently. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

43% of revenue comes from outside the United States.

Revenue by geography, FY2025
  • United States57%$142M
  • Other Countries25%$62M
  • Germany7%$18M
  • Canada6%$15M
  • United Kingdom5%$13M

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMMar 2026
Income statement
$89M$101M$106M$117M$129M$154M$162M$193M$220M$250M$256MRevenueRevenue
71%70%70%68%65%66%65%66%69%72%72%Gross marginGross mgn
16%17%17%16%17%17%18%16%16%17%17%SG&A / revenueSG&A/rev
7%7%8%8%8%8%8%9%7%6%6%R&D / revenueR&D/rev
$16M$21M$28M$21M$29M$36M$27M$37M$52M$68M$73MOperating incomeOp. inc.
18.3%20.9%26.7%18.1%22.3%23.6%16.6%19.0%23.8%27.2%28.5%Operating marginOp. mgn
$11M$17M$23M$18M$21M$27M$21M$30M$44M$58M$62MNet incomeNet inc.
35%19%19%17%22%22%25%24%23%23%23%Effective tax rateTax rate
Cash flow & returns
$17M$23M$20M$14M$35M$35M$25M$37M$44M$81M$87MOperating cash flowOp. cash
$4M$4M$4M$5M$8M$11M$9M$10M$10M$10M$10MDepreciationDeprec.
$1M($620K)($10M)($12M)$2M($6M)($9M)($8M)($16M)$5M$7MWorking capital & otherWC & other
$3M$6M$3M$4M$3M$5M$3M$7M$7M$7M$8MCapexCapex
3.2%6.4%2.9%3.2%2.3%3.2%2.0%3.8%3.2%2.7%3.2%Capex / revenueCapex/rev
$14M$19M$16M$10M$32M$30M$22M$29M$37M$74M$79MOwner earningsOwner earn.
15.8%18.7%15.6%8.9%24.6%19.6%13.7%15.2%16.9%29.8%30.9%Owner earnings marginOE mgn
$14M$16M$16M$10M$32M$30M$22M$29M$37M$74M$79MFree cash flowFCF
15.8%16.3%15.6%8.9%24.6%19.6%13.7%15.2%16.9%29.8%30.9%Free cash flow marginFCF mgn
$14M$12M$21M$73M$0$0$899K$0$2M$2MAcquisitionsAcquis.
$3M$4M$5M$7M$8M$9M$11M$12M$14M$18M$19MDividends paidDiv. paid
$311K$778K$741K$683K$570K$802K$642K$853K$2M$2MBuybacksBuybacks
17%19%22%13%12%12%8%10%8%10%10%ROICROIC
12%16%18%12%12%11%8%10%13%15%15%Return on equityROE
8%12%13%8%8%7%4%6%9%10%11%Retained to equityRetained/eq
Balance sheet
$24M$42M$48M$33M$27M$14M$19M$24M$26M$28M$27MCash & investmentsCash+inv
$13M$15M$16M$17M$20M$20M$22M$25M$30M$34M$36MReceivablesReceiv.
$1M$2M$2M$3M$2M$2M$3M$4M$2M$4M$4MAccounts payablePayables
$32M$13M$14M$14M$17M$17M$19M$21M$28M$30M$52MOperating working capitalOper. WC
$59M$80M$94M$92M$94M$140M$162M$195M$402M$468M$478MCurrent assetsCur. assets
$10M$13M$20M$21M$25M$22M$25M$30M$31M$36M$33MCurrent liabilitiesCur. liab.
5.6×6.1×4.8×4.4×3.7×6.4×6.4×6.5×13.1×12.9×14.3×Current ratioCurr. ratio
$23M$24M$30M$40M$66M$66M$66M$66M$66M$66M$66MGoodwillGoodwill
$102M$126M$153M$188M$253M$293M$310M$347M$552M$616M$630MTotal assetsAssets
$0$36M$0$0$168M$169M$169MTotal debtDebt
($33M)$9M($14M)($24M)$142M$140M$142MNet debt / (cash)Net debt
1166.9×1004.9×14104.5×22.0×16.4×254.9×13.1×14.1×Interest coverageInt. cov.
$88M$110M$130M$148M$173M$254M$268M$298M$337M$394M$407MShareholders’ equityEquity
1.9%2.2%2.2%2.3%2.3%2.3%2.6%2.7%3.0%3.1%3.1%Stock comp / revenueSBC/rev
Per share
19.2M20.0M20.2M20.3M20.5M21.5M22.2M22.4M22.8M22.9M23.0MShares out (diluted)Shares
$4.63$5.04$5.22$5.77$6.32$7.19$7.29$8.63$9.65$10.89$11.13Revenue / shareRev/sh
$0.55$0.86$1.13$0.88$1.04$1.25$0.93$1.34$1.93$2.52$2.71EPS (diluted)EPS
$0.73$0.94$0.81$0.51$1.55$1.41$1.00$1.31$1.63$3.25$3.44Owner earnings / shareOE/sh
$0.73$0.82$0.81$0.51$1.55$1.41$1.00$1.31$1.63$3.25$3.44Free cash flow / shareFCF/sh
$0.17$0.21$0.27$0.33$0.38$0.43$0.50$0.56$0.63$0.79$0.84Dividends / shareDiv/sh
$0.15$0.32$0.15$0.19$0.15$0.23$0.15$0.32$0.31$0.30$0.36Cap. spending / shareCapex/sh
$4.55$5.48$6.43$7.29$8.43$11.83$12.10$13.29$14.81$17.16$17.66Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+10.0%/yr+11.5%/yr
Owner earnings / share+18.0%/yr+15.9%/yr
EPS+18.4%/yr+19.4%/yr
Dividends / share+18.4%/yr+16.0%/yr
Capital spending / share+8.0%/yr+15.2%/yr
Book value / share+15.9%/yr+15.3%/yr

The year, in the company's words

the filing →

Verbatim from the 10-K's management discussion. Each sentence is shown only because its subject, direction, and stated figures check out against the filed numbers on this page. The words are the company's; the arithmetic is the record's.

  • Revenue+13.5%
    “Net sales increased by $29.7 million, or 14%, to $249.6 million for the year ended December 31, 2025, compared to $219.9 million for the year ended December 31, 2024. The increase was driven primarily by higher average selling prices, higher unit volumes shipped to customers, the European launch of Artegraft, and additional sales representatives.”
    ✓ figure matches the filed record

The record, charted

FY2016–2025

Each measure over its full record; the current point and the worst year marked.

Share count
23Mpeak FY2025
ROIC
10%low FY2022
Gross margin
72%low FY2022
Net debt ÷ owner earnings
1.9×peak FY2024

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$74Mowner earningsvs.$58Mnet incomelow FY2019

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $58M of profit into $74M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$58M
Owner earnings$74M · 30% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$58M$44M$30M$21M$27M
Depreciation & amortizationnon-cash charge added back+$10M+$10M+$10M+$9M+$11M
Stock-based compensationreal costnon-cash, but a real cost+$8M+$7M+$5M+$4M+$3M
Working capital & othertiming of cash in and out, other non-cash items+$5M−$16M−$8M−$9M−$6M
Cash from operations$81M$44M$37M$25M$35M
Capital expenditurecash put back in to keep running and to grow−$7M−$7M−$7M−$3M−$5M
Owner earnings$74M$37M$29M$22M$30M
Owner-earnings marginowner earnings ÷ revenue30%17%15%14%20%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $8M), owner earnings is nearer $67M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $68M ÷ interest expense $5M
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • How heavy is the debt, net of cash? $140M · 2.1× operating profit
    Meaningful net debt
    Cash $28M + ST investments $214K − debt $169M
    What this means

    Netting $28M of cash and short-term investments against $169M of debt leaves $140M owed, about 2.1× a year's operating profit (2.5× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 49 + DIO 101 − DPO 19 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Solid through the cycle
    10-yr median, range 8%–22%; 10% latest = NOPAT $52M ÷ invested capital $534M
    Industry peers: median -9%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 10% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • High through the cycle
    10-yr median margin, range 9%–30%; latest $74M = operating cash $81M − maintenance capex $7M
    Industry peers: median -24%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 30% of revenue this year, a 16% median across 10 years. Treating stock comp as the real expense it is (less $8M of SBC) leaves $67M.

  • Cash-backed
    Cash from ops $81M ÷ net income $58M
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Reinvests most of it
    Dividends + buybacks $20M ÷ Owner Earnings $74M
    What this means

    Of $74M Owner Earnings, $20M (27%) went back to shareholders, $18M dividends, $2M buybacks. But the buybacks barely exceed stock issued to employees ($8M SBC), net of dilution, little was truly returned. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.

  • Investing or harvesting? 0.65×
    Harvesting
    Capex $7M ÷ depreciation $10M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 5 of 6 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $250M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 12.89×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $169M vs $432M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Pass
    A profit every year (10-yr record) · no losses
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Pass
    Uninterrupted dividends · paid every year (10)
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth Pass
    Earnings +33% over the record · +160%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $1.92/share (latest year $2.53), the averaged base the calculator's gate runs on, and book value is $17.22/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 10 of 10
    What this means

    Never lost money over the record, the earnings stability Graham insisted on.

  • Return on capital ≥ 15% 0 of 6 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 22% → 23% (3-yr avg ends)

    In the filing’s words The filing ties gains to its own pricing, but names price competition too — pricing power that is real yet contested, not unopposed. The margin shows who is winning.

    What this means

    Through the cycle the operating margin held roughly steady — about 22% early, 23% lately, median 21%.

  • Reinvestment, incremental ROIC 10%
    What this means

    Reinvested capital came back at only a modest incremental return — near the cost of capital, where extra growth adds little per dollar. The record shows whether it is a soft stretch or a thinning moat.

  • Owner earnings growth +15%/yr
    What this means

    Owner earnings grew about 15% a year over the record.

  • Worst year 2022 · 16.6% op. margin
    What this means

    Stayed profitable even in its hardest year, the resilience that survives recessions.

  • Share count +2.0%/yr
    What this means

    The share count is rising, dilution works against you on a per-share basis.

  • Dividend record rising
    What this means

    Paid and raised the dividend across the record, the continuity Graham prized.

  • How management talks about it Promotional
    What this means

    The record is compounding, but the filing leans on a promoter’s vocabulary rather than the per-share, return-on-capital terms an owner uses. The results back the talk here; the register is still worth noting.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$478M
  • Cash & short-term investments$27M
  • Receivables$36M
  • Inventory$20M
  • Other current assets$395M
Current liabilities$33M
  • Accounts payable$4M
  • Other current liabilities$29M
Current ratio14.32×all current assets ÷ what's due · Graham looked for 2×
Quick ratio13.71×stricter: inventory excluded
Cash ratio0.81×strictest: cash alone against what's due
Working capital$444Mthe cushion left after near-term bills
Revenue, latest quarter vs. a year ago+11.2%the freshest read on whether the business is still growing
Current ratio, recent quarters8.4× → 14.3×
Deeper floors
Tangible book value$309Mequity stripped of goodwill & intangibles
Net current asset value$255MGraham's net-net: current assets less all liabilities
Debt incl. operating leases$21M$21M of it operating leases
Deferred revenue$188Kcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $331M of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested$48M · 15%
  • Dividends$93M · 28%
  • Buybacks$9M · 3%
  • Retained (debt / cash)$181M · 55%
  • Returned to owners$102M

    36% of the owner earnings the business produced over the span, $93M as dividends and $9M as buybacks.

  • Average price paid for buybacks$42.77

    Across the years where the filing reports a share count, 0M shares were bought for $4M, about $42.77 each. Year to year the price paid ranged from $33.28 (2019) to $53.59 (2023), and 2023, near the top of that range, was also its heaviest buyback year ($853K).

  • Net change in share count19.7%

    The diluted count rose from 19M to 23M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.

  • Dividend record$0.79/sh

    Paid in 10 of the years on record, the per-share dividend growing about 18% a year. It was never cut over the span.

  • Return on what it retained18%

    Of the earnings it kept rather than paid out ($168M over the span), annual owner earnings (first three years vs last three) grew $31M, so each retained $1 added about 0.18 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$99M16% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity17%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$123Mover 10 years buying other businesses, against $48M of capital spent building

None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid.

  • Insider ownership7.4%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • CEO pay ratio43:1

    What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.

  • Stock-based compensation$8M

    The slice of the business handed to employees in shares this year, 3% of revenue, equal to 12% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why LeMaitre Vascular Inc. is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2016–2025.

2 of the 5 tests turned up something to look into; the other 3 came back clean.

  • Look hereDid the share count rise anyway?19.7%

    Diluted shares grew 19.7% over 2016–2025, even as the company spent $9M on buybacks. The repurchases were outrun by issuance — to staff, in a raise, or in a deal — and the filing says which; owners' slice still shrank. Read the buyback line beside this one, not on its own.

  • Look hereAre "one-time" charges a yearly habit?10 of 10 years

    Management took an impairment or write-down in 10 of the last 10 years, $12M in all. A charge taken almost every year is not one-time; it is the business — past deals coming due, and an admission the assets were worth less than what was paid. Munger's rule: when the "one-time" keeps happening, it is the business. Read it beside the goodwill the company still carries.

And these came back clean
  • Is it less profitable than it was?
  • Did reported profit become cash?
  • Did receivables and inventory outpace sales?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
GKOSGlaukos Corporation$507M76%-25.2%-8%-3%
MDXGMiMedx Group Inc$419M84%-0.3%34%8%
ANGOAngioDynamics Inc.$320M54%-12.3%-9%-0%
PRCTPROCEPT BioRobotics Corporation$308M51%-93.9%-115%-96%
LMATLeMaitre Vascular Inc.$250M68%21.6%12%16%
KIDSOrthoPediatrics Corp.$236M74%-16.9%-7%-24%
CERSCerus Corporation$234M58%-40.9%-43%-31%
SIBNSI-BONE Inc.$201M88%-36.2%-21%-38%
Group median71%-21.0%-9%-14%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what LeMaitre Vascular Inc. has delivered.

LeMaitre Vascular Inc.’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

$

Through the cycle, LeMaitre Vascular Inc. earns about $41M on its 16.3% median owner-earnings margin. This year’s 29.8% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base

The assumptions

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25+21%/yr
Owner-earnings growth · ’16→’25+16%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Free cash flow $79M on 23M shares outstanding, per the 10-Q cover, as of 2026-05-04; net debt $142M. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. Capex ($8M) runs well above depreciation ($10M), so this is a build-out; Steady-state swaps total capex for maintenance (≈ depreciation), lifting the base to about $81M, the cash it would throw off if it stopped expanding. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "LeMaitre Vascular Inc. (LMAT), the owner's record," https://ownerscorecard.com/c/LMAT, data as of 2026-07-09.

Manual order: ← LLYVK its page in the Manual LMB →

Industry order: ← LIVN the Medical Devices & Equipment chapter MASI →